|
AU2012202801A1
|
|
Treatment or prophylaxis of asthma
|
|
WO2010032139A1
|
|
Bacterial and fungal vaccines for the treatment of asthma
|
|
KR20180132178A
|
|
Non-typeable haemophilus influenzae vaccines and their uses
|
|
WO2008109958A1
|
|
Methods for evaluation of oral vaccines
|
|
WO2008109957A1
|
|
Method for determining suitability of treatment for asthma or chronic airways disease
|
|
KR20150089097A
|
|
Treatment or prophylaxis of asthma
|
|
EP1793848A1
|
|
Method for determining dosage for an oral killed vaccine
|
|
EP1838329A1
|
|
Method for providing oral killed vaccines
|
|
AU2005274680A1
|
|
Oral killed vaccines and method for providing same
|
|
US7655248B2
|
|
Compositions and methods for treatment of candidiasis
|
|
AU2001258060B2
|
|
Compositions and methods for treatment of mucosal infections
|
|
EP1305042A1
|
|
Compositions comprising non-typable Haemophilus influenzae (NTHI) and probiotic bacteria for the treatment of mucosal infections caused by NTHI
|
